27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Between the potential for government health care reform and new online competition from Amazon.com, Inc. (NASDAQ:AMZN) and others, 2018 could be a notable year for health care stocks. One Wall Street analyst sees more pros than cons in the managed care space.
The Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Jefferies analyst David Windley upgraded Humana Inc (NYSE:HUM) from Hold to Buy and raised the price target to $333.
Windley upgraded Anthem Inc (NYSE:ANTM) from Hold to Buy and raised the price target to $283.
The Thesis
Managed care stocks stocks could see significant earnings upside over the next three years, Windley said in a Friday note. (See the analyst's track record here.)
“Growth in government programs, persistent low utilization trends, disciplined pricing and tax reform benefits make MCOs still an attractive sector,” the analyst said.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Investors should anticipate a series of upward earnings revisions in the space in 2018 — and tax reform could boost EPS potential by up to 34 percent for leading MCO companies, according to Jefferies.
Humana will see the most EPS tailwind from the federal tax bill of all MCO stocks Jefferies covers, and Medicare Advantage margins could grow to between 4.5 percent and 5 percent for Humana by 2019, Windley said.
Jefferies has confidence in Humana’s new CEO, and Windey said the company’s new pharmacy benefit manager initiative will produce EPS of around $2.50 by 2021.
In addition to the upgrades of Anthem and Humana, Jefferies maintains Buy ratings on Centene Corp (NYSE:CNC), CIGNA Corporation (NYSE:CI) and UnitedHealth Group Inc (NYSE:UNH).
Price Action
Anthem shares closed Friday up 2.05 percent at $239.82, while Humana shares were up 1.04 percent at $268.02 at the close.
Related Links:
Key Takeaways From The J.P. Morgan Healthcare Conference
3 Likely Health Care Disruptors In 2018
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.